Jonathan N. Glickman

Active 1983–2025

108
Papers
32,329
Citations
85
h-index
106
i10-index

Citations

Citations per year for Jonathan N. Glickman1971: 1 citations1984: 11 citations1985: 13 citations1986: 15 citations1987: 13 citations1988: 11 citations1989: 14 citations1990: 31 citations1991: 26 citations1992: 23 citations1993: 35 citations1994: 21 citations1995: 26 citations1996: 24 citations1997: 24 citations1998: 22 citations1999: 20 citations2000: 17 citations2001: 22 citations2002: 53 citations2003: 77 citations2004: 108 citations2005: 105 citations2006: 123 citations2007: 143 citations2008: 192 citations2009: 268 citations2010: 347 citations2011: 383 citations2012: 363 citations2013: 414 citations2014: 556 citations2015: 537 citations2016: 532 citations2017: 577 citations2018: 527 citations2019: 1,240 citations2020: 1,308 citations2021: 1,382 citations2022: 1,120 citations2023: 959 citations2024: 1,308 citations2025: 780 citations2026: 32 citations1972–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,265 citing papers, 27.9% of this breakdownChina: 2,938 citing papers, 15.6% of this breakdownUnited Kingdom: 989 citing papers, 5.2% of this breakdownGermany: 974 citing papers, 5.2% of this breakdownItaly: 701 citing papers, 3.7% of this breakdownJapan: 701 citing papers, 3.7% of this breakdownFrance: 622 citing papers, 3.3% of this breakdownCanada: 599 citing papers, 3.2% of this breakdownAustralia: 476 citing papers, 2.5% of this breakdownNetherlands: 433 citing papers, 2.3% of this breakdownSpain: 389 citing papers, 2.1% of this breakdownSwitzerland: 350 citing papers, 1.9% of this breakdown
0%27.9%Other 23.4%

Fields

  • Biochemistry, Genetics and Molecular Biology47.3%
  • Medicine30.8%
  • Immunology and Microbiology12.5%
  • Nursing2.8%
  • Agricultural and Biological Sciences1.5%
  • Dentistry1.2%
  • Other3.9%

Topics

  • Gut microbiota and health12.9%
  • Immune Cell Function and Interaction3.3%
  • Clostridium difficile and Clostridium perfringens research3.3%
  • Inflammatory Bowel Disease2.4%
  • Probiotics and Fermented Foods2.2%
  • Diet and metabolism studies1.9%
  • Other74%

Coauthors

All papers

Open in search
  1. The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis

    Authors: , , , , , , , - Science 2013 cited by 5,386

  2. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment

    Authors: , , , , , , , , , , , , , , - Cell Host & Microbe 2013 cited by 2,719

  3. Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function

    Authors: , , , , , , , , , , - Science 2012 cited by 1,659

  4. An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease

    Authors: , , , , , , , , , , , , - Science Translational Medicine 2015 cited by 446

  5. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 727

  6. Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity

    Authors: , , , , , , , , , , , - Immunity 2019 cited by 329

  7. XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease

    Authors: , , , , , , , , , , - Cell 2008 cited by 1,402

  8. CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function

    Authors: , , , , , , , , - Cell Reports 2015 cited by 401

  9. Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression

    Authors: , , , , , , , , , - Gut Microbes 2021 cited by 151

  10. Paneth cells as a site of origin for intestinal inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2013 cited by 731

  11. Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut

    Authors: , , , , , , , , , , , , , , - Cell Host & Microbe 2023 cited by 129

  12. Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function

    Authors: , , , , - Science 2020 cited by 202

  13. Faecalibaculum rodentium remodels retinoic acid signaling to govern eosinophil-dependent intestinal epithelial homeostasis

    Authors: , , , , , , , , , - Cell Host & Microbe 2022 cited by 123

  14. Enterobacteriaceae Act in Concert with the Gut Microbiota to Induce Spontaneous and Maternally Transmitted Colitis

    Authors: , , , , , , , , , , , , - Cell Host & Microbe 2010 cited by 799

  15. Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 1,289

  16. Endoplasmic reticulum stress in the intestinal epithelium initiates purine metabolite synthesis and promotes Th17 cell differentiation in the gut

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew K. Waldor, Jun R. Huh, Arthur Kaser, Richard S. Blumberg - Immunity 2023 cited by 84

  17. Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice

    Authors: , , , , , , , , , , , , - Gastroenterology 2020 cited by 99

  18. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2009 cited by 775

  19. The Crohn’s disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response

    Authors: , , , , , , , , , , , , , , , - eLife 2019 cited by 152

  20. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum

    Authors: , , , , , , , - mBio 2021 cited by 79

  21. Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System

    Authors: , , , , , , , - Cell 2007 cited by 935

  22. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission

    Authors: , , , , , , , , , , , , , , - The ISME Journal 2014 cited by 396

  23. Intelectin-1 binds and alters the localization of the mucus barrier–modifying bacterium Akkermansia muciniphila

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard S. Blumberg - The Journal of Experimental Medicine 2022 cited by 38

  24. Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype

    Authors: , , , , , , , , , , , , - Clinical Cancer Research 2009 cited by 419